Hydrokortison Evolan

Hydrokortison Evolan is a topical medication that contains the corticosteroid hydrocortisone as its active ingredient. It is supplied in a cream/ointment form (strength not specified) and is marketed within the European Union. As a glucocorticoid, it is intended for local anti‑inflammatory and immunosuppressive action on the skin. The product is used under medical guidance for various dermatologic conditions and may be applied according to prescribed regimens by a healthcare professional.

Hydrokortison Evolan is employed in dermatology for its anti‑inflammatory and immunosuppressive properties when applied to the skin.

- Management of mild to moderate eczema and atopic dermatitis. - Relief of symptoms associated with contact dermatitis or allergic skin reactions. - Treatment of localized psoriasis plaques. - Soothing of insect bite reactions and minor skin irritations. - Adjunct therapy for superficial fungal infections to reduce inflammation.

Adverse reactions to topical hydrocortisone are generally localized, but systemic effects can occur with extensive or prolonged use.

Common: - Mild burning or stinging at the application site. - Transient itching or irritation. - Dryness or flaking of the treated skin. - Redness (erythema) that resolves after discontinuation. - Folliculitis or acneiform eruptions.

Serious: - Skin atrophy or thinning with prolonged use. - Development of telangiectasia (visible small blood vessels). - Secondary bacterial, fungal, or viral infection of the skin. - Allergic contact dermatitis to the formulation. - Systemic adrenal suppression when large areas are treated for extended periods.

When using Hydrokortison Evolan, several safety considerations should be observed to minimize risks.

- Avoid application on broken, infected, or ulcerated skin unless directed by a clinician. - Limit duration of use; prolonged therapy can increase the risk of skin atrophy. - Do not cover the treated area with occlusive dressings unless specifically advised. - Use with caution in pediatric patients, as children are more susceptible to systemic absorption. - Discuss use during pregnancy or lactation with a healthcare professional, as safety data are limited. - Monitor for signs of secondary infection and discontinue if infection develops.

Topical hydrocortisone may interact with other dermatologic agents, affecting efficacy or safety.

Avoid: - Concurrent use of other potent topical corticosteroids on the same area, which can increase systemic absorption. - Application of topical antibiotics or antifungals that may be inactivated by the steroid's anti‑inflammatory action.

Use with caution: - Combining with retinoids or keratolytic agents, which may increase skin irritation. - Use alongside systemic corticosteroids, as additive immunosuppressive effects may occur. - Application with photosensitizing drugs, as steroid use can mask early signs of phototoxic reactions.